Abstract: The present invention provides an antisense oligonucleotide that is formed of 15-22 nucleotides and that is complementary to a nucleic acid including at least 15 consecutive bases in a specific target region of a base sequence of SEQ ID NO: 471, or a pharmaceutically acceptable salt thereof, or hydrates of those.

Abstract: A substrate processing apparatus includes: a batch processing section that includes batch processing units each provided with a processing tank that stores a processing liquid, and immerses substrates in the processing liquid stored within the processing tank and collectively performs a liquid processing on the substrates; a single-wafer processing section that includes a single-wafer processing unit that processes the substrates processed in the batch processing section, one by one; a standby section that includes an immersion tank that stores an immersion liquid, and stands by the substrates processed by the batch processing section, while being immersed in the immersion liquid; and a conveyance system that conveys the substrates from the standby section to the single-wafer processing section, and includes a first substrate conveyance unit that takes out the substrates immersed in the immersion liquid within the immersion tank one by one from the immersion liquid.

Abstract: An organic compound having a hole-transport property and a low refractive index is provided. An organic compound represented by General Formula (G1) shown below is provided. In General Formula (G1), Ar1 represents a substituted or unsubstituted arylene group having 6 to 13 carbon atoms in a ring, n represents an integer of 0 or 1, and Ar2 represents an aryl group having 6 to 10 carbon atoms in a ring and includes at least one branched-chain or cyclic alkyl group having 3 to 12 carbon atoms. The total number of carbon atoms of the branched-chain or cyclic alkyl group in Ar2 is more than or equal to 6. R1 to R4 each independently represent an alkyl group having 1 to 6 carbon atoms. R11 to R14 and R21 to R24 each independently represent a hydrogen atom or an alkyl group having 1 to 4 carbon atoms. Any one of R15 to R18 and any one of R25 to R28 each represent a bond directly bonded to a nitrogen atom, and the others each independently represent a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.

Abstract: The present invention provides an antisense oligonucleotide that is formed of 15-22 nucleotides and that is complementary to a nucleic acid including at least 15 consecutive bases in a specific target region of a base sequence of SEQ ID NO: 471, or a pharmaceutically acceptable salt thereof, or hydrates of those.

Abstract: An electrode forming device has a flux application unit that applies flux on a substrate; a plurality of ball filling units that are arranged in series at a downstream side of the flux application unit and fill conductive balls on the substrate applied with the flux to form electrodes; and a first conveying device, a second conveying device, a first bypass conveyor and a second bypass conveyor that convey the substrate to one of the ball filling units and conveys the substrate in such a way as to bypass the other ball filling unit.